(Q37724505)

22 August 2017

1 reference

title

Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management (English)

1 reference

22 August 2017

0 references

1 reference

V Baliga

1

1 reference

22 August 2017

R Sapsford

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Diabetes and Vascular Disease Research

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

164-171

1 reference

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Vital epidemiologic clues in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Diabetes mellitus and congestive heart failure. Further knowledge needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Efficacy and safety of benazepril for advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

CHART: congestive cardiac failure in hospitals, an Australian review of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Prevalence of aspirin resistance in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Coagulation and atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

The influence of type 2 diabetes on fibrin structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

The phantom of lactic acidosis due to metformin in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Thiazolidinediones and Heart Failure: A teleo-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109338773

21 January 2018

Identifiers

DOI

10.1177/1479164109338773

1 reference

22 August 2017

1 reference